Oxford Nanopore Technologies PLC
LSE:ONT

Watchlist Manager
Oxford Nanopore Technologies PLC Logo
Oxford Nanopore Technologies PLC
LSE:ONT
Watchlist
Price: 135.3 GBX 5.29% Market Closed
Market Cap: 1.3B GBX
Have any thoughts about
Oxford Nanopore Technologies PLC?
Write Note
ONT
/
Balance Sheet
/
Total Current Liabilities

Oxford Nanopore Technologies PLC
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford Nanopore Technologies PLC
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Oxford Nanopore Technologies PLC
LSE:ONT
Total Current Liabilities
£89.2m
CAGR 3-Years
7%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Total Current Liabilities
£2.6m
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Total Current Liabilities
£1.9m
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
3%
Ergomed PLC
LSE:ERGO
Total Current Liabilities
£37.3m
CAGR 3-Years
1%
CAGR 5-Years
24%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Total Current Liabilities
£1.6m
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Total Current Liabilities
£36m
CAGR 3-Years
24%
CAGR 5-Years
51%
CAGR 10-Years
40%
No Stocks Found

Oxford Nanopore Technologies PLC
Glance View

Market Cap
1.2B GBX
Industry
Life Sciences Tools & Services

Oxford Nanopore Technologies PLC stands as a pioneering force in the field of genomics, transforming the landscape of DNA and RNA sequencing. Founded as a spin-off from the University of Oxford, the company gained recognition with its distinctive nanopore sequencing technology, which radically differs from traditional sequencing methods. Traditional sequencing often involves a process that can be expensive, time-consuming, and complex. However, Oxford Nanopore's approach uses tiny, porous apertures coupled with electrical signals to read genetic codes directly. This technology allows for the sequencing of long DNA strands in real-time, providing not only speed and efficiency but also the versatility to handle a wide range of samples, from environmental to clinical applications. By making sequencing more accessible and portable through their critically acclaimed MinION device, the company has managed to capture significant interest and investment from researchers across diverse scientific fields. The business model of Oxford Nanopore Technologies is built upon a strategic blend of product sales, including their sequencing devices and associated consumables, alongside providing commercial sequencing services. Their revenue streams are anchored by the MinION, GridION, and PromethION devices, each catering to varied throughput needs and scales of operation. Sales of these devices are complemented by a continuous income from consumable sales, essential for each sequencing run, which helps to embed their technology deeply within the workflows of their users. Additionally, the company's expansion into data analysis services further diversifies their income, utilizing their specialized expertise to assist customers in interpreting and utilizing complex genomic data. This multifaceted approach not only solidifies their position in the genomics market but also ensures multiple pathways for generating sustained revenue growth.

ONT Intrinsic Value
187.63 GBX
Undervaluation 28%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Oxford Nanopore Technologies PLC's Total Current Liabilities?
Total Current Liabilities
89.2m GBP

Based on the financial report for Dec 31, 2023, Oxford Nanopore Technologies PLC's Total Current Liabilities amounts to 89.2m GBP.

What is Oxford Nanopore Technologies PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
33%

Over the last year, the Total Current Liabilities growth was -13%. The average annual Total Current Liabilities growth rates for Oxford Nanopore Technologies PLC have been 7% over the past three years , 33% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.